
Sign up to save your podcasts
Or


Still using androgen deprivation therapy (ADT) alone for patients with metastatic hormone-sensitive prostate cancer (mHSPC)? Learn the latest on optimizing outcomes with combination therapies.
Credit available for this activity expires: 6/25/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/new-era-mhspc-treatment-evaluating-emerging-doublet-and-2026a1000kt7?ecd=bdc_podcast_libsyn_mscpedu
New strategies for tackling nicotine in at-risk groups.
Credit available for this activity expires: 06/25/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/health-risks-nicotine-use-focus-risk-populations-2026a1000eyj?ecd=bdc_podcast_libsyn_mscpedu
Optimize depression care: Master shared decision-making and integrate novel MOAs, fast-acting therapies, and validated assessment tools.
Credit available for this activity expires: 6/25/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/best-practices-clinician-patient-shared-decision-making-2026a1000kiq?ecd=bdc_podcast_libsyn_mscpedu
Why did early cholesteryl ester transfer protein (CETP) inhibitors fail despite raising high-density lipoprotein cholesterol (HDL-C), and how does contemporary evidence change the therapeutic outlook?
Credit available for this activity expires: 6/24/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/cetp-inhibition-what-weve-learned-and-whats-next-quickfire-2026a1000kip?ecd=bdc_podcast_libsyn_mscpedu
Anxiety frequently co-occurs with adult attention-deficit/hyperactivity disorder (ADHD). Learn how this comorbidity compounds emotional dysregulation and executive dysfunction.
Credit available for this activity expires: 6/24/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/clinic-managing-emotional-dysregulation-and-executive-2026a1000kog?ecd=bdc_podcast_libsyn_mscpedu
Break through the limits of traditional phosphate binders. Discover how novel nonbinder therapies can change hyperphosphatemia care in DD-CKD.
Credit available for this activity expires: 6/24/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/data-dialysis-unit-integrating-novel-therapies-2026a1000kax?ecd=bdc_podcast_libsyn_mscpedu
Beyond hemodynamics: rewriting the future of nondiabetic CKD care.
Credit available for this activity expires: 6/19/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/https://www.medscape.org/viewarticle/hot-press-new-evidence-emerging-therapies-nondiabetic-ckd-2026a1000k2g?ecd=bdc_podcast_libsyn_mscpedu
How can automated insulin delivery optimize insulin therapy in patients with type 2 diabetes? Hear expert faculty discuss!
Credit available for this activity expires: 6/16/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/ask-experts-best-practices-using-aid-solve-titration-2026a1000jqb?ecd=bdc_podcast_libsyn_mscpedu
Help stop nicotine addiction before it starts by understanding marketing strategies used by the nicotine industry to target advertising to youth.
Credit available for this activity expires: 06/18/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/marketing-influence-related-nicotine-containing-products-2026a1000bgr?ecd=bdc_podcast_libsyn_mscpedu
Are you using the most-effective behavioral strategies to help patients quit nicotine and prevent relapse?
Credit available for this activity expires: 06/18/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/behavioral-and-non-pharmacologic-interventions-nicotine-2026a1000fug?ecd=bdc_podcast_libsyn_mscpedu
From the publisher's feed

136 Listeners

697 Listeners

496 Listeners

162 Listeners

103 Listeners

892 Listeners

13 Listeners

16 Listeners

290 Listeners

265 Listeners

3,343 Listeners

1,157 Listeners

195 Listeners

93 Listeners

520 Listeners

372 Listeners

170 Listeners

60 Listeners

8 Listeners

431 Listeners